Related Experiment Video

Updated: May 3, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.3K

Meta-analysis and gene set analysis of archived microarrays suggest implication of the spliceosome in metastatic and

Bertrand De Meulder1, Fabrice Berger1, Eric Bareke2

  • 1Microorganism Biology Research Unit -NARILIS, University of Namur, Namur, Belgium.

Plos One
|February 6, 2014
PubMed

Insights

This study uncovers the spliceosome

Area of Science:

  • Molecular Biology
  • Bioinformatics
  • Cancer Research

Background:

  • Cancer cells adapt to low oxygen (hypoxia), promoting metastasis.
  • Publicly available DNA chip data offers insights into cancer adaptation.
  • Understanding these molecular mechanisms is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the molecular mechanisms of cancer cell adaptation to hypoxia.
  • To identify genes differentially expressed during hypoxic adaptation and metastasis.
  • To explore novel molecular players involved in cancer metastasis.

Main Methods:

  • Utilized a meta-analysis approach on public DNA chip data.
  • Developed and adapted bioinformatics tools for sensitive gene expression analysis.
  • Compared Over-Representation Analysis (ORA) and Functional Class Scoring (FCS) for gene discovery.

Main Results:

  • Validated existing knowledge of cancer cell adaptation to hypoxia.
  • Discovered the previously unrecognized role of the spliceosome in metastasis.
  • Identified differentially expressed genes critical for the metastatic phenotype.

Conclusions:

  • The spliceosome is a key player in cancer cell metastasis under hypoxic conditions.
  • Bioinformatic meta-analysis of public data is a powerful tool for discovering novel biological insights.
  • This research opens new avenues for targeting spliceosome function in cancer therapy.

More Related Videos

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

6.8K
Using the E1A Minigene Tool to Study mRNA Splicing Changes10:25

Using the E1A Minigene Tool to Study mRNA Splicing Changes

Published on: April 22, 2021

4.5K

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
53.3K